Polyradiculoneuropathy, Chronic Inflammatory Demyelinating research hub

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

This study is testing a new medicine called nipocalimab for adults with a nerve condition called CIDP. It wants to see if nipocalimab is safe and effective at stopping CIDP symptoms from returning, compared to a dummy medicine, after patients have improved on nipocalimab first.